BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 33590401)

  • 61. Pattern-of-failure and salvage treatment analysis after chemoradiotherapy for inoperable stage III non-small cell lung cancer.
    Taugner J; Eze C; Käsmann L; Roengvoraphoj O; Gennen K; Karin M; Petrukhnov O; Tufman A; Belka C; Manapov F
    Radiat Oncol; 2020 Jun; 15(1):148. PubMed ID: 32517716
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Adverse Radiation Effect and Disease Control in Patients Undergoing Stereotactic Radiosurgery and Immune Checkpoint Inhibitor Therapy for Brain Metastases.
    Koenig JL; Shi S; Sborov K; Gensheimer MF; Li G; Nagpal S; Chang SD; Gibbs IC; Soltys SG; Pollom EL
    World Neurosurg; 2019 Jun; 126():e1399-e1411. PubMed ID: 30902777
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Salvage stereotactic radiosurgery for breast cancer brain metastases: outcomes and prognostic factors.
    Kelly PJ; Lin NU; Claus EB; Quant EC; Weiss SE; Alexander BM
    Cancer; 2012 Apr; 118(8):2014-20. PubMed ID: 21918959
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Survival Benefit of Stereotactic Radiotherapy in the Complex Management of Metastatic Melanoma.
    Kelemen G; Együd Z; Dobi Á; Varga L; Kószó R; Borzási E; Paczona V; Végváry Z; Borzák F; Fodor E; Ócsai H; Baltás E; Oláh J; Hideghéty K
    Anticancer Res; 2024 Jan; 44(1):205-212. PubMed ID: 38159978
    [TBL] [Abstract][Full Text] [Related]  

  • 65. First experience and clinical results using a new non-coplanar mono-isocenter technique (HyperArc™) for Linac-based VMAT radiosurgery in brain metastases.
    Alongi F; Fiorentino A; Gregucci F; Corradini S; Giaj-Levra N; Romano L; Rigo M; Ricchetti F; Beltramello A; Lunardi G; Mazzola R; Ruggieri R
    J Cancer Res Clin Oncol; 2019 Jan; 145(1):193-200. PubMed ID: 30382369
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Single-fraction radiosurgery versus fractionated stereotactic radiotherapy in patients with brain metastases: a comparative study.
    Loo M; Pin Y; Thierry A; Clavier JB
    Clin Exp Metastasis; 2020 Jun; 37(3):425-434. PubMed ID: 32185576
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Survival after surgery and stereotactic radiosurgery for patients with multiple intracranial metastases: results of a single-center retrospective study.
    Smith TR; Lall RR; Lall RR; Abecassis IJ; Arnaout OM; Marymont MH; Swanson KR; Chandler JP
    J Neurosurg; 2014 Oct; 121(4):839-45. PubMed ID: 24857242
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Clinical outcomes in patients with brain metastases from breast cancer treated with single-session radiosurgery or whole brain radiotherapy.
    Mix M; Elmarzouky R; O'Connor T; Plunkett R; Prasad D
    J Neurosurg; 2016 Dec; 125(Suppl 1):26-30. PubMed ID: 27903186
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Gamma Knife Radiosurgery for Metastatic Brain Tumors from Cancer of Unknown Primary.
    Matsunaga S; Shuto T; Kobayashi N
    World Neurosurg; 2019 Feb; 122():e1465-e1471. PubMed ID: 30468925
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Hypofractionated stereotactic radiotherapy with or without whole-brain radiotherapy for patients with newly diagnosed brain metastases from non-small cell lung cancer.
    Ma LH; Li G; Zhang HW; Wang ZY; Dang J; Zhang S; Yao L; Zhang XM
    J Neurosurg; 2012 Dec; 117 Suppl():49-56. PubMed ID: 23205789
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Prognostic effect of symptomatic extracranial lesions on survival of recursive partitioning analysis Class III brain metastatic patients treated with stereotactic radiotherapy.
    Chen XJ; Xiao JP; Li XP; Jiang XS; Zhang Y
    J Cancer Res Ther; 2016; 12(1):215-20. PubMed ID: 27072240
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A comparison of survival rates for treatment of melanoma metastatic to the brain.
    Stone A; Cooper J; Koenig KL; Golfinos JG; Oratz R
    Cancer Invest; 2004; 22(4):492-7. PubMed ID: 15565805
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases.
    Kondziolka D; Patel A; Lunsford LD; Kassam A; Flickinger JC
    Int J Radiat Oncol Biol Phys; 1999 Sep; 45(2):427-34. PubMed ID: 10487566
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Inhomogeneous tumor dose distribution provides better local control than homogeneous distribution in stereotactic radiotherapy for brain metastases.
    Lucia F; Key S; Dissaux G; Goasduff G; Lucia AS; Ollivier L; Pradier O; Schick U
    Radiother Oncol; 2019 Jan; 130():132-138. PubMed ID: 30017105
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Stereotactic radiosurgery alone versus resection plus whole-brain radiotherapy for 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
    Rades D; Bohlen G; Pluemer A; Veninga T; Hanssens P; Dunst J; Schild SE
    Cancer; 2007 Jun; 109(12):2515-21. PubMed ID: 17487853
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Brain metastasis formation and irradiation by stereotactic radiation therapy combined with immunotherapy: A systematic review.
    Pin Y; Paix A; Todeschi J; Antoni D; Proust F; Noël G
    Crit Rev Oncol Hematol; 2020 May; 149():102923. PubMed ID: 32199131
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Linear accelerator-based stereotactic radiosurgery in 140 brain metastases from malignant melanoma.
    Hauswald H; Stenke A; Debus J; Combs SE
    BMC Cancer; 2015 Jul; 15():537. PubMed ID: 26201853
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases.
    Mehta MP; Tsao MN; Whelan TJ; Morris DE; Hayman JA; Flickinger JC; Mills M; Rogers CL; Souhami L
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):37-46. PubMed ID: 16111570
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Radiosurgery and fractionated stereotactic radiotherapy in oligometastatic/oligoprogressive non-small cell lung cancer patients: Results of a multi-institutional series of 198 patients treated with "curative" intent.
    Buglione M; Jereczek-Fossa BA; Bonù ML; Franceschini D; Fodor A; Zanetti IB; Gerardi MA; Borghetti P; Tomasini D; Di Muzio NG; Oneta O; Scorsetti M; Franzese C; Romanelli P; Catalano G; Dell'Oca I; Beltramo G; Ivaldi GB; Laudati A; Magrini SM; Antognoni P;
    Lung Cancer; 2020 Mar; 141():1-8. PubMed ID: 31926440
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Stereotactic radiosurgery for patients with brain metastases from small cell lung cancer.
    Wegner RE; Olson AC; Kondziolka D; Niranjan A; Lundsford LD; Flickinger JC
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e21-7. PubMed ID: 21345622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.